Abstract
P-288 A model to predict the risk of prolonged thrombocytopenia recovery in relapsed/ refractory multiple myeloma patients after anti-BCMA CAR-T treatment
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
